Portal hypertension and its prognostic implications in patients with Wilson's disease.
Lukas BurghartPeter FerenciOleksandr PetrenkoMattias MandorferMichael SchwarzMichael GschwantlerMichael TraunerThomas ReibergerAlbert Friedrich StättermayerPublished in: Alimentary pharmacology & therapeutics (2024)
Patients with Wilson's disease developing features of CSPH are at an increased risk for hepatic decompensation and liver-related mortality, warranting for regular screening and timely initiation of effective CSPH-directed treatments.